SEC Form D private-offering filing
DeepCyte Inc.
A new SEC Form D private-offering notice from Wilmington, DE, a $1,740,000 filer-stated offering target. The source filing is one click away.
AI powered single cell metabolomics platform that predicts and identifies mechanisms of drug toxicity for biopharma drug development
Filed 2026-01-29Filed to raise $1,740,000First money in 2026-01-15Raised so far $1,445,536HQ (as filed) Wilmington, DEStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified deepcyte.bio↗Named in the filing 1 executive & director
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.